Abdurahman Alloghbi
Physician
EXPERIENCE
2022-PRESENT
Assistant Professor
King Khalid University
I joined department of oncology as an Assistant Professor, Abha, Saudi Arabia.
2019-2022
Fellow Doctor
Karmanos Cancer Center
I completed a combined fellowship program of hematology and medical oncology, Detroit, MI, USA
2016-2019
University of Toledo
Resident Doctor
I completed a 3-year program in Internal Medicine at University of Toledo, Ohio, USA
2015-2016
Research Fellow
University of Toledo
I completed a year of research in the University of Toledo, Ohio, USA
EDUCATION
2022
American Board of Oncology
After finishing a 3-year program in Medical Oncology, I passed the American Board examination in adult oncology
2022
American Board of Hematology
After finishing a 3-year program in Hematology, I passed the American Board examination in adult hematology
2019
American Board of Internal Medicine
After finishing a 3-year program in Internal Medicine, I passed the American Board examination in Internal Medicine
2018
American Board of Medical Quality
After participating in Medical Quality projects at the University of Toledo, Ohio, USA, I passed the American Board examination in Medical Quality
2014
Educational Commission For Foreign Medical Graduates (ECFMG)
After passing USMLE Step 1, USMLE Step 2 CS, and USMLE Step 2 CK examinations, I obtained the ECFMG certificate
2005-2012
Bachelor of Medicine, Bachelor of Surgery (MBBS)
After joining medical school at King Khalid University, Abha, Saudi Arabia. I obtained MBBS upon graduation in 2012
PRESENTATIONS
Presented medical-related topics in the following institutions
PUPLICATIONS
Click here for full list of publications
Romidepsin Treatment in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review and Meta-Analysis. American Journal of Therapeutics (2021) [click here to view]
Gastrointestinal stromal tumor: a review of current and emerging therapies. Cancer Metastasis Rev (2021) [click here to view]
Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies. Medicina (2019) [click here to view]
PIK3CA gene aberrancy and role in targeted therapy of solid malignancies. Cancer Gene Ther (2020) [click here to view]
Fatal Myocardial Infarction Secondary to Daunorubicin in Acute Myeloid Leukemia Patient. Coron Heart Dis (2017) [click here to view]
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy. Future Sci OA. (2019) [click here to view]
Primary Follicular Lymphoma of the Spleen Presenting as a Solitary Splenic Mass. Poster presentation, 2018 ACP Ohio, Columbus, Ohio, United States
Pre-Operative Red Blood Cell Transfusion for Correction of Anemia Prior to Cardio-Thoracic Surgery Leads to Increased Mortality in Patients with Diabetes Mellitus and Hypertension. Retrospective study. Presented in 2018 ACP Ohio, Columbus, Ohio, United States
AWARDS
Dan Olson Award for Excellence in Patient Care, Quality Measures and Commitment to the Profession
Award of recognition of the physician whose patient care is recognized as exemplary. 2019. University of Toledo, Ohio, USA
AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) PRESENTATIONS
Molecular and immune landscape of FH-mutated kidney cancer [click here to view]
Associations between micro-geographic social vulnerability and disparities in cancer incidence [click here to view]
Prognostic utility of preoperative and postoperative circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis [click here to view]
Hepatic arterial infusion chemotherapy versus trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A systematic review and meta-analysis [click here to view]
Outcomes with novel combinations in nonclear cell renal cell carcinoma (nccRCC): ORACLE study [click here to view]
EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) PRESENTATIONS
The molecular and immune landscape of recurrent head and neck squamous cell carcinoma (HNSCC) in patients undergoing definitive therapy [click here to view]
SOCIAL AWARENESS CONTRIBUTIONS
Dr. Alloghbi is actively involved in promoting cancer awareness in society.
TV APPEARANCES
Dr. Alloghbi asserts that media, including TV, can serve as a powerful instrument for promoting societal awareness.
EDUCATIONAL PROJECTS
eMedStudy
More than 10,000 subscribers joined eMedStudy platform
MentorMe
A new innovative platform the will be launched soon.
Click here
AREAS OF INTERST
RESEARCH
Interested in collaborating with researchers from different backgrounds to produce meaningful scholarly work
EDUCATION
Interested in participating in education-related projects aiming to improve the educational experience of our students and trainees
PATIENT CARE
Interested in participating in projects that have a direct or indirect positive impact on the well-being of our patients
READ WITH ME
Endpoints in Oncology
Target Audience: Oncology Fellows
Link: here
FH-mutated cancers
Target Audience: Oncologists
Link: here
الحلول الرقمية التعليمية
السرطان..المرض القابل للشفاء
الفئة المستهدفة: أعضاء هيئة التدريس
الرابط: هنا
الفئة المستهدفة: عام
الرابط: هنا
Building your success
Target Audience: General
Link: here
لماذا تخصص طب الأورام؟
الفئة المستهدفة: الطالب والطالبات
الرابط: هنا
..I am privileged to be surrounded by exceptional individuals who believe that challenges bring opportunities, hurdles are tools for growth, and failures are the quickest path to success in today's age...
TESTIMONIALS
Dr. Alloghbi consistently went above and beyond for his students with encouragement, feedback, positivity and keeping us involved. His knowledge base and methodology for evaluating patients is phenomenal.
OFFICIAL EVALUATION OF RESIDENT PRECEPTORS. UNIVERSITY OF TOLEDO, OHIO, USA
Dr. Alloghbi is very talented, inquisitive, and enthusiastic. I am thoroughly impressed by his innovative and critical thinking. His fund of oncology knowledge is above the level of a second year fellow. I have no doubt he will make an exceptional oncologist.
OFFICIAL EVALUATION OF A FELLOW IN TRAINING. WAYNE STATE UNIVERSITY, MI, USA